This technology has vast potential to help patients but remains underutilized and underappreciated. The tools are there. What’s lacking are harmonized controls, regulatory guidelines and database ...

America's Growth Leaders Cytek Biosciences has been recognized by TIME as one of America’s Growth Leaders of 2026. Presented in partnership with global data firm Statista, the ranking recognizes the ...

A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact ...

The transcription factor HEB synergizes with TCR signaling to upregulate Id3, which is required for the maturation of fetal IL-17-producing γδ T cells.

The implementation of VCE scoring in clinical practice could inform early pre-emptive therapeutic interventions, exclusively ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...

The global Life Science Instrumentation Market, valued at US$63.4 billion in 2025, is projected to advance at a resilient CAGR of 6.5% from 2025 to 2031, culminating in a forecasted valuation of US$92 ...

New research reveals that women with long COVID show distinct biological disruptions — including gut inflammation, anemia, and abnormal hormone levels — that may explain their heightened and ...

Acute lymphoblastic leukaemia (ALL) affects the blood and bone marrow and is the most common type of childhood cancer, with 400 children diagnosed in the UK each year 1. There are two different groups ...

Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.